{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:06:07Z","timestamp":1770138367838,"version":"3.49.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005160","name":"American Society of Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005160","name":"American Society of Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.trre.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T05:27:07Z","timestamp":1529472427000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hypertension guidelines: How do they apply to kidney transplant recipients"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-3889","authenticated-orcid":false,"given":"Fahad","family":"Aziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-2168","authenticated-orcid":false,"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Mandelbrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-6128","authenticated-orcid":false,"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2018.06.002_bb0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(02)11403-6","article-title":"Comparative risk assessment collaborating G. Selected major risk factors and global and regional burden of disease","volume":"360","author":"Ezzati","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.06.002_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0002-9149(99)00635-9","article-title":"Elevated systolic blood pressure as a cardiovascular risk factor","volume":"85","author":"Kannel","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.trre.2018.06.002_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0020","series-title":"Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","author":"Bethesda","year":"2010"},{"key":"10.1016\/j.trre.2018.06.002_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","article-title":"Hypertension after renal transplantation","volume":"21","author":"Ponticelli","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0030","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","article-title":"Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0035","unstructured":"[Available from: https:\/\/www.usrds.org\/atlas10.aspx."},{"key":"10.1016\/j.trre.2018.06.002_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1525-139X.2003.16026.x","article-title":"Clinical epidemiology of cardiac disease in renal transplant recipients","volume":"16","author":"Rigatto","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.trre.2018.06.002_bb0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia","volume":"14","author":"Rigatto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0050","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0b013e3181a76775","article-title":"Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring","volume":"87","author":"Paoletti","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trre.2010.02.001","article-title":"Hypertension in the kidney transplant recipient","volume":"24","author":"Wadei","year":"2010","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2018.06.002_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2018.06.002_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.ASN.0000104574.04006.08","article-title":"Blood pressure and the survival of renal allografts from living donors","volume":"15","author":"Mange","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure","volume":"53","author":"Opelz","year":"1998","journal-title":"Collab Transplant Study Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0075","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved long-term outcomes after renal transplantation associated with blood pressure control","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/2141-9248.149793","article-title":"Modifiable risk factors of hypertension and socio-demographic profile in Oghara, Delta state; prevalence and correlates","volume":"5","author":"Ibekwe","year":"2015","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.trre.2018.06.002_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000450796","article-title":"The triad of sleep apnea, hypertension, and chronic kidney disease: a Spectrum of common pathology","volume":"7","author":"Aziz","year":"2016","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12916-015-0340-5","article-title":"Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis","volume":"13","author":"Lafranca","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2215\/CJN.04030609","article-title":"Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients","volume":"5","author":"Molnar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0100","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0041-1345(98)00513-2","article-title":"Posttransplant hypertension","volume":"30","author":"Curtis","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(85)90627-0","article-title":"Benefits of removal of native kidneys in hypertension after renal transplantation","volume":"2","author":"Curtis","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.06.002_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9343(85)90009-9","article-title":"Hypertension after successful renal transplantation","volume":"79","author":"Curtis","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transproceed.2015.12.020","article-title":"Risk factors for hypertension after living donor kidney transplantation in Korea: a multivariate analysis","volume":"48","author":"Yu","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1681\/ASN.V781131","article-title":"Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families","volume":"7","author":"Guidi","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0125","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.transproceed.2012.09.086","article-title":"Cardiovascular risk in recipients with kidney transplants from expanded criteria donors","volume":"44","author":"Blanca","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0272-6386(93)70097-I","article-title":"Nephron underdosing: a programmed cause of chronic renal allograft failure","volume":"21","author":"Brenner","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0135","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra011078","article-title":"Subtle acquired renal injury as a mechanism of salt-sensitive hypertension","volume":"346","author":"Johnson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000072819","article-title":"Effect of donor\/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation","volume":"23","author":"El-Agroudy","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5414\/CNP57409","article-title":"Hypertension in renal transplantation: donor and recipient risk factors","volume":"57","author":"Ducloux","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0150","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.2004100882","article-title":"ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation","volume":"16","author":"Hauser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0160","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","article-title":"Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity","volume":"22","author":"Joy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FPC.0b013e328328d4e9","article-title":"Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function","volume":"19","author":"Grisk","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.trre.2018.06.002_bb0170","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00007890-199612150-00011","article-title":"Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine","volume":"62","author":"Taler","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0175","first-page":"123","article-title":"Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy","volume":"5","author":"Curtis","year":"1976","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000180750","article-title":"Effect of alternate-day steroids on renal transplant function. A controlled study","volume":"17","author":"Mcdonald","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.trre.2018.06.002_bb0185","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2004.00765.x","article-title":"Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2018.06.002_bb0195","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.47.6.1297","article-title":"Variations in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity, and the dose of prednisone","volume":"47","author":"Popovtzer","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2018.06.002_bb0200","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.1987.102","article-title":"Hypertension in renal transplant recipients","volume":"31","author":"Luke","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0205","doi-asserted-by":"crossref","first-page":"381s","DOI":"10.1042\/cs061381s","article-title":"Does long-term low-dose corticosteroid therapy cause hypertension?","volume":"61","author":"Jackson","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trre.2018.06.002_bb0210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ki.1987.131","article-title":"Mechanisms of glucocorticoid-induced hypertension","volume":"31","author":"Whitworth","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00863455","article-title":"Cyclosporine-induced transient renal hypoperfusion in adolescent transplant recipients","volume":"10","author":"Dello Strologo","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0220","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ki.1996.183","article-title":"Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant","volume":"49","author":"Perico","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-199207000-00009","article-title":"Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation","volume":"54","author":"Perico","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0230","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0235","doi-asserted-by":"crossref","first-page":"F284","DOI":"10.1152\/ajprenal.90647.2008","article-title":"Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterol","volume":"296","author":"Wang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trre.2018.06.002_bb0240","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","article-title":"Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2)","volume":"22","author":"Esteva-Font","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0250","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/HJH.0b013e32835165e4","article-title":"Hypertension after kidney transplantation: calcineurin inhibitors increase salt-sensitivity","volume":"30","author":"Hoorn","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.trre.2018.06.002_bb0255","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"European Tacrolimus vs Ciclosporin microemulsion renal transplantation study G. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.06.002_bb0260","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/ndt\/gfn004","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin a in renal transplantation: three-year observational results","volume":"23","author":"Kramer","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0265","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/TP.0b013e31820c10eb","article-title":"Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)","volume":"91","author":"Vanrenterghem","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0280","first-page":"98","article-title":"Ten years experience with belatacept-based immunosuppression after kidney transplantation","volume":"6","author":"Grannas","year":"2014","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.trre.2018.06.002_bb0285","article-title":"Belatacept for kidney transplant recipients","volume":"11","author":"Masson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trre.2018.06.002_bb0290","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"90","author":"Larsen","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0295","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.RVI.0000141338.62574.F4","article-title":"Transplant renal artery stenosis: outcome after percutaneous intervention","volume":"15","author":"Beecroft","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trre.2018.06.002_bb0300","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiology.219.3.r01jn30663","article-title":"Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty","volume":"219","author":"Patel","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.trre.2018.06.002_bb0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/ajkd.1998.v31.pm9428466","article-title":"Renal artery stenosis in kidney transplants","volume":"31","author":"Fervenza","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.ASN.0000099379.61001.F8","article-title":"Transplant renal artery stenosis","volume":"15","author":"Bruno","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0315","first-page":"250950","article-title":"Clinical insight into the precaval right renal artery: a multidetector row computed tomography angiographic study","volume":"2013","author":"Srivastava","year":"2013","journal-title":"ISRN Anat"},{"key":"10.1016\/j.trre.2018.06.002_bb0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000242431","article-title":"Incidence, predictors and outcomes of transplant renal artery stenosis after kidney transplantation: analysis of USRDS","volume":"30","author":"Hurst","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0325","first-page":"580","article-title":"Transplant renal artery stenosis","volume":"48","author":"Roberts","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00000658-197503000-00007","article-title":"Arterial stenosis complicating renal allotransplantation in man: a study of 38 cases","volume":"181","author":"Lacombe","year":"1975","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2018.06.002_bb0335","doi-asserted-by":"crossref","first-page":"v74","DOI":"10.1093\/ndt\/gfg1054","article-title":"Renal transplant artery stenosis","volume":"18","author":"Buturovic-Ponikvar","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0340","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1600-6143.2005.00927.x","article-title":"Management of arterial stenosis affecting kidney graft perfusion: a single-Centre study in 53 patients","volume":"5","author":"Voiculescu","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004439","article-title":"Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry","volume":"10","author":"Valle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.trre.2018.06.002_bb0350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ckj\/sfu132","article-title":"Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy","volume":"8","author":"Chen","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.trre.2018.06.002_bb0355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1432-2277.1990.tb01911.x","article-title":"Transplant renal artery stenosis: experience and comparative results between surgery and angioplasty","volume":"3","author":"Benoit","year":"1990","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.trre.2018.06.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13217","article-title":"Angioplasty vs stent in the treatment of transplant renal artery stenosis","volume":"32","author":"Chen","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0365","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0003319710377076","article-title":"Management of transplant renal artery stenosis","volume":"62","author":"Seratnahaei","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.trre.2018.06.002_bb0370","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0970-1591.189707","article-title":"Transplant renal artery stenosis: the impact of endovascular management and their outcomes","volume":"32","author":"Patil","year":"2016","journal-title":"Indian J Urol"},{"key":"10.1016\/j.trre.2018.06.002_bb0375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00000658-200301000-00016","article-title":"Surgical repair of transplant renal artery stenosis with preserved cadaveric iliac artery grafts","volume":"237","author":"Shames","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2018.06.002_bb0380","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1681\/ASN.V22s37","article-title":"Pathophysiology and treatment of posttransplant hypertension","volume":"2","author":"Luke","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0385","series-title":"Prevention and treatment of antibody-mediated rejection of the renal allograft","author":"Arjang Djamali","year":"2018"},{"key":"10.1016\/j.trre.2018.06.002_bb0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trre.2018.06.002_bb0395","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.trre.2018.06.002_bb0400","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0009922814536776","article-title":"Hypertension during intravenous immune globulin infusion for Kawasaki's disease: an underreported phenomenon?","volume":"54","author":"Kissel","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.trre.2018.06.002_bb0405","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0410","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/hrt.2009.192104","article-title":"Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies","volume":"97","author":"Wei","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.trre.2018.06.002_bb0415","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1590\/S0004-27302004000500012","article-title":"Primary aldosteronism\u2014actual epidemics or false alarm?","volume":"48","author":"Gordon","year":"2004","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.trre.2018.06.002_bb0420","first-page":"261","article-title":"Hypokalemia secondary to primary hyperaldosteronism in a renal transplant recipient","volume":"24","author":"Cook","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0425","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70056-3","article-title":"Primary hyperaldosteronism causing posttransplantation hypertension: localization by adrenal vein sampling","volume":"31","author":"Fahmy","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0430","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00007890-200004150-00050","article-title":"Unmasking of primary hyperaldosteronism by renal transplantation","volume":"69","author":"Kaplan","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0435","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/17.6.1129","article-title":"Hypokalaemia and hypertension early after kidney transplantation","volume":"17","author":"Tintillier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0440","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD","volume":"62","author":"Taler","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0445","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2018.06.002_bb0450","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trre.2018.06.002_bb0455","volume":"2017","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.trre.2018.06.002_bb0460","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group SR","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0465","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1715163517743525","article-title":"Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: an update","volume":"151","author":"Lamb","year":"2018","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.trre.2018.06.002_bb0470","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinternmed.2011.619","article-title":"Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the kidney early evaluation program (KEEP)","volume":"172","author":"Peralta","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0475","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.06.002_bb0480","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2015.07.059","article-title":"Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies","volume":"66","author":"Emdin","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2018.06.002_bb0485","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.trre.2018.06.002_bb0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-159-4-201308200-00004","article-title":"Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study","volume":"159","author":"Kovesdy","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0495","first-page":"122","article-title":"Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study","volume":"70","author":"van Riemsdijk","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0500","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000137793.23371.42","article-title":"Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study","volume":"78","author":"Kuypers","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0505","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1046\/j.1523-1755.1998.06826.x","article-title":"Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin","volume":"68","author":"Martinez-Castelao","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.trre.2018.06.002_bb0510","first-page":"2598","article-title":"Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study","volume":"26","author":"Morales","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0515","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(96)90246-2","article-title":"Pharmacology of immunosuppressive medications used in renal diseases and transplantation","volume":"28","author":"de Mattos","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0520","first-page":"1311","article-title":"Effects of nicardipine on blood cyclosporine levels in renal transplant patients","volume":"28","author":"Guan","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0525","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.06.002_bb0530","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2018.06.002_bb0535","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.06.002_bb0540","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0545","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.trre.2018.06.002_bb0550","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1681\/ASN.2012080777","article-title":"Angiotensin II blockade in kidney transplant recipients","volume":"24","author":"Ibrahim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0555","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0560","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/TP.0000000000000938","article-title":"The association between renin-angiotensin system blockade and long-term outcomes in renal transplant recipients: the Wisconsin allograft recipient database (WisARD)","volume":"100","author":"Shin","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0565","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0570","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0575","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00007890-198808000-00009","article-title":"Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys","volume":"46","author":"Huysmans","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0580","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2003.tb00306.x","article-title":"Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients","volume":"16","author":"Suwelack","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0585","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000355135","article-title":"Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?","volume":"38","author":"Taber","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0590","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2011.01242.x","article-title":"Hypertension in kidney transplant recipients","volume":"24","author":"Ponticelli","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0595","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2016.12.017","article-title":"Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with Tacrolimus: a randomized crossover trial","volume":"69","author":"Moes","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0600","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ndt\/gfs429","article-title":"Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases","volume":"28","author":"Morales","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0605","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.transproceed.2017.01.075","article-title":"Spironolactone in post-transplant proteinuria: a safe alternative therapy","volume":"49","author":"de Sousa","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.06.002_bb0610","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0615","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TP.0b013e3181caeead","article-title":"Reduction in cardiovascular death after kidney transplantation","volume":"89","author":"Pilmore","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0620","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/j.1600-6143.2011.03734.x","article-title":"Coronary artery disease in a large renal transplant population: implications for management","volume":"11","author":"Kahn","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0625","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2009.06.032","article-title":"Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies","volume":"55","author":"Lentine","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.06.002_bb0630","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1093\/ndt\/gfl298","article-title":"Cardiovascular risk factors in renal transplantation\u2014current controversies","volume":"21","author":"Marcen","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0635","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000091","article-title":"Beta and angiotensin blockades are associated with improved 10-year survival in renal transplant recipients","volume":"2","author":"Aftab","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trre.2018.06.002_bb0640","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trre.2018.06.002_bb0645","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1681\/ASN.2007040503","article-title":"Systolic dysfunction portends increased mortality among those waiting for renal transplant","volume":"19","author":"de Mattos","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0650","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/00007890-200212150-00016","article-title":"Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile","volume":"74","author":"Ferreira","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0655","doi-asserted-by":"crossref","first-page":"59103","DOI":"10.18632\/oncotarget.19260","article-title":"Effect of earlier-proteinuria on graft functions after one-year living donor renal transplantation","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trre.2018.06.002_bb0660","doi-asserted-by":"crossref","first-page":"c7","DOI":"10.1159\/000105138","article-title":"Chronic kidney disease management: comparison between renal transplant recipients and nontransplant patients with chronic kidney disease","volume":"107","author":"Akbari","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.trre.2018.06.002_bb0665","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2215\/CJN.01310211","article-title":"Posttransplantation proteinuria: an approach to diagnosis and management","volume":"6","author":"Shamseddin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.06.002_bb0670","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0675","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0680","first-page":"135","article-title":"De novo post-transplant thrombotic microangiopathy localized only to the graft in autosomal dominant polycystic kidney disease with thrombophilia","volume":"4","author":"Rolla","year":"2015","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.trre.2018.06.002_bb0685","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1667\/RR2400.1","article-title":"Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation","volume":"175","author":"Moulder","year":"2011","journal-title":"Radiat Res"},{"key":"10.1016\/j.trre.2018.06.002_bb0690","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.trre.2018.06.002_bb0695","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/TP.0b013e318234b337","article-title":"Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II","volume":"92","author":"Kelsch","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0700","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0705","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nep.12421","article-title":"Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation","volume":"20","author":"Jobert","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.trre.2018.06.002_bb0710","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-199403150-00005","article-title":"Erythrocytosis after renal transplantation. The response to theophylline treatment","volume":"57","author":"Ilan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0715","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1399-0012.2007.00760.x","article-title":"Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients","volume":"22","author":"Kedzierska","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2018.06.002_bb0720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1523-1755.2001.00773.x","article-title":"Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway","volume":"60","author":"Gossmann","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.06.002_bb0725","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00007890-199709270-00021","article-title":"Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines","volume":"64","author":"Morrone","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.06.002_bb0730","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI118484","article-title":"Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline","volume":"97","author":"Azizi","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2018.06.002_bb0735","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI10557","article-title":"Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice","volume":"106","author":"Cole","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X18300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X18300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:23:09Z","timestamp":1661473389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X18300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0955470X18300284"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2018.06.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension guidelines: How do they apply to kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}